Monday, March 3rd, 2008
Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced the completion of patient enrollment in its Phase 2a clinical trial for MB07803, a product candidate being studied as a treatment for patients with type 2 diabetes. With this trial fully enrolled and the final patients undergoing dosing, the Company expects to be able to ...
Posted in Diabetes | No Comments »
Monday, February 25th, 2008
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer). IMC-1121B, an anti-vascular endothelial growth ...
Posted in Liver Disease / Hepatitis | No Comments »
Saturday, February 23rd, 2008
CMS has ordered California-based health insurer Health Net to stop marketing and enrollment for its "Health Net Orange" Medicare prescription drug plans, according to a notice on a government Web site, Florida Health News reports. The freeze was enacted because the company failed to process enrollment applications on time and ...
Posted in Health Insurance | No Comments »
Monday, February 18th, 2008
The University of Southern California (USC) and Second Sight Medical Products Inc, a leading developer of retinal prostheses for treating blindness, announced that they have completed enrollment of the first phase of a US FDA approved clinical study of the Argus II Retinal Prosthesis System. Second Sight also announced that ...
Posted in Eye Health / Optometry | No Comments »
